Ultimate Guide to Combating Coronavirus Ultimate Guide to Combating Coronavirus

ADVERTISEMENT

Mistletoe Injections for Tumor Treatment

Analysis by Dr. Joseph Mercola Fact Checked

mistletoe injection

Story at-a-glance -

  • Mistletoe injections have demonstrated effective results in several trials based in Europe, extending life and reducing symptoms associated with cancer
  • Most people will either have a personal experience or know someone who has cancer as an estimated 1.7 million new cases of cancer will be diagnosed in the U.S. in 2018; the most common of which are breast, lung, prostate and colorectal cancers
  • Suzanne Somers, actress, author and health advocate, was diagnosed with breast cancer in 2011 and chose to use natural strategies, including mistletoe extract to successfully treat her disease
  • Although chemotherapy may make breast cancer aggressive and more likely to spread, other natural treatment options may offer similar, if not better, results

According to the National Cancer Institute, an estimated 1.7 million new cases of cancer will be diagnosed in the United States in 2018. The most common cancers are breast cancer, lung and bronchus cancer, prostate cancer and colon and rectum cancer. Cancer mortality is higher in women than in men and over 35 percent of men and women will be diagnosed with cancer at some point in their life.

Based solely on statistics, it is likely most people either have a personal experience with or know someone who has had cancer. Emerging scientific data show the development of cancer as not a genetic problem but rather a metabolic disease, primarily rooted in mitochondrial dysfunction.


Read the Full Article for Free!
Subscribe to the #1 Natural Health Newsletter
  • Unlock censored health information that Google doesn't want you to read
  • Keep your privacy secure — We are no longer active on Facebook and are blocking our content from Google search to ensure your privacy stays protected
  • Get access to all of Dr. Mercola's health articles, E-books and special reports

Existing Subscribers: Enter your email address for instant access